Page last updated: 2024-10-25

ciprofloxacin and Porphyria Cutanea Tarda

ciprofloxacin has been researched along with Porphyria Cutanea Tarda in 2 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Porphyria Cutanea Tarda: An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mazzarolo, SS1
Degiovanni, CV1
Darley, CR1

Other Studies

2 other studies available for ciprofloxacin and Porphyria Cutanea Tarda

ArticleYear
Blistering eruption on the leg of an adult.
    American family physician, 2011, Jul-15, Volume: 84, Issue:2

    Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Blister; Ciprofloxacin; Dermatitis Herpetiformis; D

2011
Pseudoporphyria occurring during a course of ciprofloxacin.
    Clinical and experimental dermatology, 2008, Volume: 33, Issue:1

    Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; False Positive Reactions; Hand;

2008